Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Senseonics, TypeZero Join Forces On Artificial Pancreas

Executive Summary

Diabetes companies Senseonics and TypeZero Technologies have signed a research and development licensing agreement to develop an artificial pancreas.

Advertisement

Related Content

Advent Of Artificial Pancreas Tech To Galvanize Fast-Growing Diabetes Market
Cellnovo Targets 2018 Launch Of Insulin Micropump With Artificial Pancreas Tech
US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel